StockData
Cresco Labs Inc. logo

Cresco Labs Inc. (CRLBF) stock

CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 6, 2026Score 4/30
$0.58−0.02 (-3.13%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Earnings

Cresco Labs's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q4 FY2024
$176.00M
-6.4% on a year earlier
EPS, Q4 FY2024
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Cresco Labs's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2024ended Dec 31, 2024Mar 12, 2025during market hours$176.00M-6.4%–Release
Q4 FY2023ended Dec 31, 2023Mar 13, 2024during market hours$188.00M––Release
Q4 FY2022ended Dec 31, 2022Mar 16, 2023after the close–––Release
Q4 FY2021ended Dec 31, 2021Apr 1, 2022during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Cresco Labs has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Cresco Labs puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Cresco Labs filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?